Santen Pharmaceutical Statistics
Total Valuation
SNPHY has a market cap or net worth of 3.78 billion. The enterprise value is 3.37 billion.
Market Cap | 3.78B |
Enterprise Value | 3.37B |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | Sep 29, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -5.01% |
Shares Change (QoQ) | -0.75% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 327.92M |
Valuation Ratios
The trailing PE ratio is 15.60.
PE Ratio | 15.60 |
Forward PE | n/a |
PS Ratio | 1.88 |
PB Ratio | 1.98 |
P/TBV Ratio | 2.68 |
P/FCF Ratio | 10.42 |
P/OCF Ratio | 9.28 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.62, with an EV/FCF ratio of 9.30.
EV / Earnings | 13.93 |
EV / Sales | 1.66 |
EV / EBITDA | 7.62 |
EV / EBIT | 10.49 |
EV / FCF | 9.30 |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.12.
Current Ratio | 2.58 |
Quick Ratio | 1.90 |
Debt / Equity | 0.12 |
Debt / EBITDA | 0.52 |
Debt / FCF | 0.63 |
Interest Coverage | 44.59 |
Financial Efficiency
Return on equity (ROE) is 12.14% and return on invested capital (ROIC) is 9.16%.
Return on Equity (ROE) | 12.14% |
Return on Assets (ROA) | 7.14% |
Return on Invested Capital (ROIC) | 9.16% |
Return on Capital Employed (ROCE) | 14.98% |
Revenue Per Employee | 520,497 |
Profits Per Employee | 62,887 |
Employee Count | 3,849 |
Asset Turnover | 0.71 |
Inventory Turnover | 2.72 |
Taxes
In the past 12 months, SNPHY has paid 77.65 million in taxes.
Income Tax | 77.65M |
Effective Tax Rate | 24.49% |
Stock Price Statistics
The stock price has decreased by -4.43% in the last 52 weeks. The beta is 0.22, so SNPHY's price volatility has been lower than the market average.
Beta (5Y) | 0.22 |
52-Week Price Change | -4.43% |
50-Day Moving Average | 11.34 |
200-Day Moving Average | 10.52 |
Relative Strength Index (RSI) | 46.02 |
Average Volume (20 Days) | 3,933 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNPHY had revenue of 2.00 billion and earned 242.05 million in profits. Earnings per share was 0.69.
Revenue | 2.00B |
Gross Profit | 1.14B |
Operating Income | 322.51M |
Pretax Income | 317.07M |
Net Income | 242.05M |
EBITDA | 442.36M |
EBIT | 322.51M |
Earnings Per Share (EPS) | 0.69 |
Balance Sheet
The company has 621.02 million in cash and 228.58 million in debt, giving a net cash position of 392.45 million.
Cash & Cash Equivalents | 621.02M |
Total Debt | 228.58M |
Net Cash | 392.45M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.90B |
Book Value Per Share | 5.60 |
Working Capital | 917.96M |
Cash Flow
In the last 12 months, operating cash flow was 406.87 million and capital expenditures -44.49 million, giving a free cash flow of 362.38 million.
Operating Cash Flow | 406.87M |
Capital Expenditures | -44.49M |
Free Cash Flow | 362.38M |
FCF Per Share | n/a |
Margins
Gross margin is 57.01%, with operating and profit margins of 16.10% and 12.09%.
Gross Margin | 57.01% |
Operating Margin | 16.10% |
Pretax Margin | 15.83% |
Profit Margin | 12.09% |
EBITDA Margin | 22.08% |
EBIT Margin | 16.10% |
FCF Margin | 18.09% |
Dividends & Yields
This stock pays an annual dividend of 19.13, which amounts to a dividend yield of 173.43%.
Dividend Per Share | 19.13 |
Dividend Yield | 173.43% |
Dividend Growth (YoY) | 8,167.76% |
Years of Dividend Growth | 1 |
Payout Ratio | 33.40% |
Buyback Yield | 5.01% |
Shareholder Yield | 178.44% |
Earnings Yield | 6.41% |
FCF Yield | 9.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on April 2, 2015. It was a forward split with a ratio of 2.5.
Last Split Date | Apr 2, 2015 |
Split Type | Forward |
Split Ratio | 2.5 |
Scores
SNPHY has an Altman Z-Score of 5.07 and a Piotroski F-Score of 7.
Altman Z-Score | 5.07 |
Piotroski F-Score | 7 |